Your institution may have access to this item. Find your institution then sign in to continue.
Title
New tests.
Abstract
The article offers updates on new biomedical research in the U.S. A biological marker has been found present in the urine of patients with prostate cancer which can indicate whether the cancer is progressing and spreading. BRAHMS Diagnostica LLC has received Food and Drug Administration (FDA) approval for its procalcitonin (PCT) test system. BD Diagnostics has been given clearance from the FDA to market its BD GeneOhm C diff molecular assay.